Top Companies in China Gabapentin Market | Insights 2026

China Gabapentin Market Overview

According to 6Wresearch, the China gabapentin market is expected to increase significantly, fueled by the rising prevalence of neurological disorders and a shift toward non-opioid pain management in an aging demographic. The industry is significantly driven by the adoption of generic formulations and a growing elderly population prone to chronic nerve conditions such as post-herpetic neuralgia. Furthermore, the incorporate extended-release technologies has become a standard for large enterprises in Jiangsu and Zhejiang, as they seek to enhance patient adherence and therapeutic outcomes using sophisticated gastro-retentive matrices.

Competitive Landscape

The competitive landscape of the China gabapentin market is characterized by high-intensity competition between specialized central nervous system (CNS) manufacturers and well-established domestic generic leaders. By offering a variety of dosage forms, such as capsules, tablets, and oral solutions, leading companies maintain a dominant market share. Additionally, the market sees frequent collaborations between research-led firms and third-party manufacturers to scale production and meet the rising domestic demand.

Below is a list of key players operating in the China Gabapentin Market:

1. Jiangsu Hengrui Pharmaceuticals Co., Ltd.

A leading innovation-driven pharmaceutical giant in China, specializing in oncology and CNS treatments with a strong focus on high-end generics.

2. Yangtze River Pharmaceutical Group

One of China's largest pharmaceutical corporations, renowned for its extensive manufacturing scale and high-quality neurological product portfolio.

3. CSPC Pharmaceutical Group Limited

A major integrated group that transitioned from bulk API production to a leader in finished-dosage CNS and cardiovascular medications.

4. Huadong Medicine Co., Ltd.

A prominent player in the East China region, known for its expertise in immunosuppressants and a growing neuro-psychiatry segment.

5. Jiangsu Nhwa Pharmaceutical Co., Ltd.

A specialized leader in the Chinese CNS field, focusing on anesthesia, analgesia, and neuropathic pain management formulations.

6. Zhejiang Huahai Pharmaceutical Co., Ltd.

A key global supplier of APIs and finished generics, leveraging its international-standard facilities to serve both domestic and export markets.

7. Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Focuses on ophthalmic and cardiovascular health while maintaining a competitive presence in the analgesic and neuro-protection market.

8. Humanwell Healthcare (Group) Co., Ltd.

A leader in anesthetics and analgesics in China, providing specialized neurologics and pain management solutions.

9. Shandong Xinhua Pharmaceutical Co., Ltd.

One of the oldest and largest manufacturers of antipyretic and analgesic drugs, offering cost-effective gabapentin generics.

10. Shanghai Ecust Biomedicine Co., Ltd.

Specialized in the R&D and production of pharmaceutical intermediates and APIs, including high-purity gabapentin.

11. Zhejiang Excel Pharmaceutical Co., Ltd.

A high-tech enterprise focused on the development of cardiovascular and CNS drugs, including specialized gabapentin capsules.

12. Hangzhou Cowin Pharma Co., Ltd.

An emerging player focusing on international pharmaceutical standards and the supply of high-quality neurological APIs.

13. Wuhan Senwayer Century Chemical Co., Ltd.

A significant supplier and exporter of biochemicals and pharmaceutical raw materials for the global anticonvulsant market.

14. Guangzhou Tengyue Chemical Co., Ltd.

Provides specialized chemical services and pharmaceutical raw materials for domestic pain relief drugs.

15. Sinoway International Co., Ltd.

A veteran trading and manufacturing entity providing comprehensive pharmaceutical supply chain solutions for the Chinese domestic market.